Tapani Luukkainen
#164,859
Most Influential Person Now
Tapani Luukkainen's AcademicInfluence.com Rankings
Tapani Luukkainenphilosophy Degrees
Philosophy
#9654
World Rank
#13244
Historical Rank
Logic
#6622
World Rank
#8155
Historical Rank

Download Badge
Philosophy
Tapani Luukkainen's Degrees
- PhD Medical Sciences University of Helsinki
- Doctorate Medicine University of Helsinki
Why Is Tapani Luukkainen Influential?
(Suggest an Edit or Addition)Tapani Luukkainen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endometrial Morphology During Long‐Term Use of Levonorgestrel‐Releasing Intrauterine Devices (1986) (244)
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD (1982) (198)
- Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. (1983) (180)
- Gas-chromatographic behavior of trimethylsilyl ethers of steroids (1961) (164)
- Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years' Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine Devices (1991) (153)
- Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. (1995) (137)
- Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. (1984) (127)
- Pharmacokinetics and metabolism of RU 486. (1987) (125)
- Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. (1987) (121)
- Five years' experience with levonorgestrel-releasing IUDs. (1986) (120)
- Plasma concentrations and receptor binding of RU 486 and its metabolites in humans. (1987) (111)
- Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. (1990) (99)
- Endometrial morphology of women using a d-norgestrel-releasing intrauterine device. (1978) (99)
- Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. (2003) (98)
- Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. (1988) (96)
- Oestrogen-induced progesterone receptor in human uterus. (1975) (95)
- GOSSYPOL, A POWERFUL INHIBITOR OF HUMAN SPERMATOZOAL METABOLISM (1980) (91)
- Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. (1980) (90)
- Distribution and percentages of non-protein bound contraceptive steroids in human serum. (1982) (80)
- Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. (2003) (80)
- Sustained intrauterine release of levonorgestrel over five years. (1986) (79)
- Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. (1980) (77)
- INTRAUTERINE CONTRACEPTION WITH LEVONORGESTREL: A COMPARATIVE RANDOMISED CLINICAL PERFORMANCE STUDY (1981) (76)
- RETURN OF OVARIAN FUNCTION AFTER ABORTION (1978) (75)
- Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. (1983) (72)
- Progestin-releasing intrauterine systems. (2001) (71)
- Hepatic Impairment During the Intake of Contraceptive Pills: Clinical Trial with Postmenopausal Women (1964) (71)
- Metabolism and serum binding of RU 486 in women after various single doses. (1987) (70)
- Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent. (1982) (65)
- The levonorgestrel intrauterine system: therapeutic aspects (2000) (61)
- Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices. (1980) (59)
- The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation. (1995) (58)
- The cytoplasmic progesterone receptor of human endometrium during the menstrual cycle. (1974) (57)
- Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device. (1982) (54)
- Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200. (1983) (52)
- Liver-function Tests during Intake of Contraceptive Tablets in Premenopausal Women (1965) (50)
- A D-norgestrel-releasing IUD. (1976) (48)
- In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium. (1971) (44)
- Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device. (1980) (41)
- The use-effectiveness of the Copper-T-200 in a simulated field trial (1974) (41)
- Urinary excretion of estriol and 15α-hydroxyestriol in complicated pregnancies☆ (1971) (39)
- Immediate postabortion insertion of the copper-T (TCu-200) with eighteen months follow-up. (1974) (38)
- Randomized comparison of clinical performance of two copper-releasing IUDs, Nova-T and Copper-T-200, in Denmark, Finland and Sweden. (1979) (37)
- Progesterone-binding protein in human myometrium. Influence of metal ions on binding. (1974) (35)
- The role of mitochondria in uterine contractions (1975) (35)
- Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. (1982) (35)
- Therapeutic use of the LNG IUS, and counseling. (2001) (34)
- Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. (1990) (34)
- Biochemical and clinical aspects of the enterohepatic circulation of oestrogens. (1967) (33)
- Identification and determination of oestrogens in various biological materials in pregnancy. (1970) (33)
- Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device. (2005) (33)
- Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device. (1982) (32)
- Gas-liquid chromatographic and mass spectrometric studies on sterols in vernix caseosa, amniotic fluid and meconium. (1968) (32)
- Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles. (1997) (32)
- The Effect Of Oral Intake Of Ethyl Alcohol On The Activity Of The Pregnant Human Uterus (1967) (31)
- Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel. (1975) (31)
- Health and family planning services in the Chinese People's Republic. (1972) (31)
- Isolation and identification of 11-dehydro-estradiol-17α, a new type of urinary steroid, in the urine of pregnant women (1965) (31)
- Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435. (1982) (30)
- Milligram-scale preparative gas chromatography of steroids and alkaloids (1962) (30)
- Return of fertility after the removal of Nova T or copper T 200. (1982) (30)
- The Oxidation of Glycosides. X. Reduction of Some Methyl D-Oxo-glucopyranosides. (1958) (28)
- Vaginal contraception with gossypol: a clinical study. (1983) (28)
- Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device. (1989) (27)
- Return of ovulation after abortion and after discontinuation of oral contraceptives. (1980) (27)
- Identification and determination of neutral steroid sulphates in human foetal adrenal and liver tissue. (1970) (27)
- Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China. (1990) (27)
- Nulliparous women, IUD and pelvic infection. (1979) (27)
- Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities. (1983) (26)
- Intrauterine contraception with Nova-T and copper-T-200 during three years. (1981) (26)
- Treatment of menorrhagia with an LNG-IUS. (2007) (26)
- CHAPTER 7 – O-Methyloximes as Carbonyl Derivatives in Gas Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance† (1968) (26)
- Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device. (1982) (25)
- Discriminatory effect of anti-Pr-beta-hCG-TT antibodies on the neutralization of the biological activity of placental and pituitary gonadotropins. (1978) (25)
- Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women. (1968) (25)
- The Levonorgestrel-Releasing IUD (1988) (24)
- The effect of progestin R 2323 released from vaginal rings on ovarian function. (1975) (23)
- Two-year rates for Nova T and Copper T in a comparative study. (1980) (22)
- Combined and national experience of postmenstrual IUD insertions of Nova-T and Copper-T in a randomized study. (1979) (22)
- GAS-CHROMATOGRAPHIC STUDIES ON OESTROGENS IN THE BILE OF PREGNANT WOMEN. (1965) (22)
- A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal. (1996) (21)
- Neutral steroid sulfates in human ovarlian vein blood. (1970) (20)
- Intracervical release of levonorgestrel for contraception. (1981) (19)
- Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception. (1993) (19)
- Hydrolysis of phospholipid monolayers by human spermatozoa. Inhibition by male contraceptive gossypol. (1985) (19)
- Induction of premature labor in the rabbit after pretreatment with phospholipids. (1963) (18)
- Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules. (1985) (18)
- Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion. (1981) (18)
- ST-1435: development of an implant. (1984) (17)
- Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device. (1984) (17)
- Neutral steroid sulphates in amniotic fluid. (1970) (16)
- Immediate postabortal insertion of a levonorgestrel-releasing IUD. (1982) (15)
- Factors Affecting the Clinical Performance of Nova T and Copper T 200 (1984) (15)
- Progesterone-binding properties of microsomes from pregnant rat uterus. (1975) (13)
- GAS CHROMATOGRAPHY OF METHYLATED ESTROGENS AND APPLICATION OF THE METHOD TO THE ANALYSIS OF HUMAN LATE PREGNANCY BILE. (1963) (13)
- Issues to debate on the Women's Health Initiative: failure of estrogen plus progestin therapy for prevention of breast cancer risk. (2003) (13)
- Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD. (1978) (13)
- Contraception after thirty‐five (1992) (13)
- Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules. (1984) (13)
- Use-effectiveness of the copper-T300 during the first year. (1974) (12)
- A radioimmunoassay of oestrone in plasma. Plasma levels of oestrone and oestradiol in oophorectomized Rhesus monkeys during treatment with subcutaneous implants containing oestrone. (1978) (12)
- Pituitary and gonadal function during the use of norgestrelestradiol vaginal rings. (1978) (12)
- Hysterographic studies with the copper T (TCu 200) in situ (1972) (12)
- The Effect of œstrogen Treatment on Myometrial Activity in Late Pregnancy (1965) (11)
- Long-term clinical experience with levonorgestrel-releasing IUD. (1985) (11)
- Levonorgestrel-releasing intrauterine device. (1990) (11)
- Immediate postabortal contraception with a microdose combined preparation: suppression of pituitary and ovarian function and elimination of HCG. (1978) (11)
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435. (1981) (11)
- Intrauterine release of levonorgestrel. (1983) (11)
- The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle. (1974) (11)
- Spermatogenesis in Men Treated with Subcutaneous Application of Levonorgestrel and Estrone Rods (1981) (11)
- ISOLATION AND IDENTIFICATION OF 17α-OESTRADIOL IN THE BILE OF A PREGNANT COW (1965) (10)
- Intravaginal administration of RU 486 in humans and rats: inadequate absorption in humans. (1987) (10)
- Screening, Management, and Outcome of Pregnancy in Diabetic Mothers (1980) (10)
- Long-term contraception with norethindrone subcutaneous capsules. (1976) (9)
- The use of a contraceptive vaginal ring governed by the pattern of individual uterine bleeding. (1979) (9)
- STUDIES OF HUMAN STEROIDAL HORMONES BY GAS CHROMATOGRAPHIC TECHNIQUES. (1963) (9)
- INDUCTION OF LABOUR WITH INTRAVENOUS FAT EMULSION AT TERM (1964) (9)
- Studies on conjugated mono- and dihydroxy metabolites of progesterone in plasma, bile and urine in a human subject. (1970) (9)
- Important factors in the use-effectiveness of the copper-T-200 IUD. (1975) (9)
- Sustained intrauterine release of d-norgestrel. (1978) (9)
- Early puerperal insertions of copper-T-200. (1975) (9)
- Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception. (1979) (8)
- Intracervical release of ST-1435 for contraception. (1984) (8)
- Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginally. (1984) (8)
- Simultaneous determination of urinary estrogens, individual 11-deoxy-17-ketosteroids, total 17-ketosteroids, total 17-ketogenic steroids, pregnanediol and plasma cortisol during the menstrual cycle and in early pregnancy. (1967) (7)
- An oestrone-releasing vaginal ring in the treatment of climacteric women. (1980) (7)
- Gas Phase Chromatographic Methods for Estrogens in Biological Fluids (1968) (7)
- Acceptability of an experimental intracervical device: results of a study controlling for selection bias. (1989) (7)
- Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol. (1979) (7)
- Pharmacokinetic Studies on Low Dose Estradiol 17β Administered Orally to Postmenopausal Women (1980) (6)
- DISULPHATES OF NEUTRAL STEROIDS IN THE AMNIOTIC FLUID FROM ANENCEPHALIC PREGNANCIES (1971) (6)
- IMPORTANCE OF THE TYPE OF THE PROGESTOGEN IN ORAL CONTRACEPTIVES (1966) (6)
- Effect of Progesterone on Pregnancy: Effect of a Phospholipid Factor on the Activity of Progesterone (1961) (6)
- Multiclinic copper T studies in Finland. (1974) (5)
- The Sulphur-Sulphur Bonds in Thiothiophthene Derivatives. (1968) (5)
- A Possible regulatory role of mitochondrial calcium uptake in uterine contractions. (1974) (5)
- In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic and carcinomatous endometrium☆ (1972) (5)
- The effect of testosterone, progesterone and estrogen on the acetylating activity in rat liver and kidney preparations. (1961) (5)
- Contraception with a levonorgestrel-releasing IUD: effect on lactation and child development. (1984) (5)
- Four years of a comparative study with Nova T and Copper T 200 IUDS. (1982) (5)
- Performance of copper and steroid-releasing IUDs. (1978) (4)
- Testosterone binding of maternal plasma in twin pregnancy (1970) (4)
- Gas chromatographic and mass spectrometric identification of neutral and phenolic steroids in amniotic fluid. (1969) (4)
- Contraception with a norethisterone-releasing IUD. Plasma levels of norethisterone and its influence on the ovarian function. (1978) (4)
- Studies in the acetylation of p-aminobenzoic acid and its regulation by the sex glands in the rat organism. (1958) (4)
- Determination of Urinary Estrogens by Gas Chromatography (1965) (4)
- OESTROGEN-INDUCED PROGESTERONE RECEPTOR IN HUMAN UTERUS (1976) (4)
- [Nova-T and Copper-T 200 in a five year's clinical comparison]. (1983) (4)
- Effect of benzoic acid on the metabolic conjugations of p-aminobenzoic acid in the rat. (1958) (4)
- Effect of growth hormone and of pregnancy on the hydroxyproline concentration of the blood of rats. (1958) (4)
- Gas chromatographic and mass spectrometric studies in the influence of metabolites of bis(p-acetoxyphenyl)cyclohexylidenemethane on the estimation of estrogens in urine. (1967) (4)
- Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200 (1984) (3)
- The 1992 Indonesia Norplant Use-Dynamics Study: final report. Population Council Contract No. CI91. 99A. December 1 1991-April 30 1993 (1993) (3)
- Acetylation of p-aminobenzoic acid in various animal tissues in vitro. (1959) (3)
- Mass spectrometric studies in the specificity of estriol determination in urine by gas-liquid chromatography. (1967) (3)
- Effect of benzoate and salicylate on the acetylation of p-aminobenzoic acid in ox kidney in vitro. (1959) (3)
- Steroid methoximes II: Antifertility activity of norethisterone-3-methoxime in the rat. (1975) (3)
- [Randomized comparison of clinical performance of two copper-releasing IUDs, NOVA-T and Copper-T-200, in Denmark, Finland and Sweden with a special reference on pelvic infection]. (1979) (3)
- Microangiographic observations on the uterine and maternal placental vasculature in early human pregnancy. (1974) (3)
- GAS CHROMATOGRAPHIC IDENTIFICATION OF PREGNANEDIOL AND SOME OF ITS ISOMERS IN BILE OF PREGNANT WOMEN. (1964) (3)
- Silastic implants releasing estrone in the treatment of climacteric complaints. (1980) (3)
- Steroid methoximes I: Antifertility activity of methoxime derivatives of progesterone, estrone and 16-ketoestradiol in the rat. (1975) (3)
- Urinary excretion of estriol and 15 alpha-hydroxyestriol in complicated pregnancies. (1971) (2)
- Medicated intrauterine devices for contraception and their therapeutic effects (2006) (2)
- Liver-function Tests during Intake of Contraceptive Tablets in Pre-menopausal Women (2007) (2)
- Choice of contraceptives. (1978) (2)
- Levonorgestrel plasma concentrations and hormone profiles after 1 year of treatment with a levonorgestrel-IUD. (1980) (2)
- 146. Progesterone-binding properties of microsomes from rat myometrium (1974) (2)
- Isolation and identification of II-dehydro-estradiol-17-alpha, a new type of urinary steroid, in the urine of pregnant women. (1965) (1)
- Levonorgestrel-releasing intrauterine devices (1986) (1)
- New methods for the regulation of female fertility. (1981) (1)
- EFFECT OF HUMAN PITUITARY FOLLICLE-STIMULATING (HP-FSH) HORMONE ON URINARY EXCRETION OF 8 DIFFERENT OESTROGENS, 11-DEOXY-17-KETOSTEROIDS AND PREGNANEDIOL IN A PATIENT WITH POLYCYSTIC OVARIES (1967) (1)
- [Contraceptive coils and their problems]. (1987) (1)
- Testing the clinical performance of Nova-T versus Copper-T 200. [Abstract] (1980) (1)
- Treatment of symphyseolysis with relaxin. (1963) (1)
- Correlation of Syntocinon Sensitivity and Uterine Response at Term with the Course of Induced Labour (1964) (1)
- The effect of cortisone on the purine content in the rat spleen. (1954) (1)
- [Methods for the gas chromatography and mass spectrometry of "new oestrogens" (author's transl)]. (1971) (1)
- The levonorgestrel releasing IUD (LNG IUD) (1992) (1)
- Studies in the glucose tolerance test in STH-treated rats during pregnancy. (1958) (0)
- Nova-T/Copper-T comparative study. (1978) (0)
- BIODEGRADABLE POLYLACTATE AS A STEROID-RELEASING POLYMER: INTRAUTERINE ADMINISTRATION OF d-NORGESTREL (1975) (0)
- [Contraception in the next millenium]. (1997) (0)
- 262. Postabortal contraception with norethisterone-acetate injections (1982) (0)
- Nova-T: long-term effectiveness and clinical performance [abstract] (1983) (0)
- [Health benefits of contraception]. (1992) (0)
- CONTRACEPTION WITH A NORETHISTERONE-RELEASING IUD. PLASMA LEVELS OF NORETHISTERONE AND ITS INFLUENCE ON THE OVARIAN FUNCTION (1978) (0)
- NORETHISTERONE-3-METHOXIME IN THE RAT (1975) (0)
- Effect of phospholipids on the subcellular distribution of progesterone in pregnant rat myometrium and on protein binding of progesterone. (1972) (0)
- Effect of somatotropin (STH) on the maternal organism during pregnancy. (1957) (0)
- Intrauterine device with and without hormones (1984) (0)
- The effect on an infusion of phospholipid on the human myometrium early in pregnancy. (1963) (0)
- Urinary metabolites of p-aminobenzoic acid in man: effect of benzoate. (1959) (0)
- [Comparative results on two years use of Nova T and Copper T]. (1980) (0)
- Progestin-releasing intrauterine devices. (1997) (0)
- Testing the Clinical Performance of an IUD (1980) (0)
- [Intrauterine devices]. (1973) (0)
- 261. Intracervical contraceptive device releasing a new progestin, ST-1435 (1982) (0)
- METOPIRONE AND PLASMA SOLVOLYZABLE STEROIDS (1967) (0)
- Original research article Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up (2003) (0)
- The development of levonorgestrel IUD. (1982) (0)
- The effect of acetylsalicylic acid on the total purine content of the rat spleen. (1954) (0)
- TESTOSTERONE BINDING AND ESTROGEN EXCRETION IN NORMAL AND TWIN PREGNANCIES AND IN A PREGNANT WOMAN WITH ADDISON DISEASE (1969) (0)
- Oestradiol and depression [letter] (1993) (0)
- Coenzyme A in livers of rats treated with growth hormone (STH). (1957) (0)
- Effect of Angiotensin on Urinary Electrolytes Before and After Lipid Infusion in Early Human Pregnancy (1964) (0)
- [Is there a reason for changing the hormone treatment?]. (1990) (0)
- RECENT ADVANCES IN INTRAUTERINE CONTRACEPTION (1975) (0)
- Formation of p-aminobenzoate conjugates in rat liver and kidney in vitro. Effect of benzoate and salicylate. (1963) (0)
- Choice of contraceptives. (1978) (0)
- Development of intracervical steroid-releasing system. (1984) (0)
- [Choice of contraceptives]. (1978) (0)
- Concerns with the report from Wildemeersch et al. (2006) (0)
- Experiences with Intrauterine Blood Transfusions (1969) (0)
- Effect of the rupture of the membranes on the uterine activity. (1962) (0)
- Serum non-protein bound percentages and distribution of contraceptive steroids (1981) (0)
- [Hormonal coils]. (1987) (0)
- Combination of progestogen therapy with the conventional treatment of endometrial carcinoma. (1970) (0)
- LHRH analogs and androgens for male fertility control [abstract] (1984) (0)
- The distribution of injected C14-progesterone in the subcellular fractions of rat myometrium before and after parturition. (1967) (0)
- [One year experience of levonorgestrel-releasing intrauterine device]. (1991) (0)
- Vaginal contraception with gossypol: A clinical study (1984) (0)
- GAS CHROMATOGRAPHIC METHODS FOR URINARY OESTROGENS (1965) (0)
- [PROGESTERONE, PROGESTOGENS AND GESTAGENS]. (1963) (0)
- [Are ectopic pregnancies are reducing?]. (1997) (0)
- ISOLATION AND IDENTIFICATION OF 17-ALPHA-OESTRADIOL IN THE BILE OF A PREGNANT COW. (1965) (0)
- Discussion: long-acting contraceptive delivery systems: additional clinical studies. (1984) (0)
- [Intrauterine fetal diagnostics]. (1969) (0)
This paper list is powered by the following services: